Work

CYC065, a Potent Derivative of Seliciclib Is Active In Multiple Myeloma In Preclinical Studies

Year: 2010

Type: article

Source: Blood

DOI: 10.1182/blood.v116.21.2999.2999

Authors: Samantha Pozzi, Diana Cirstea, Loredana Santo, Doris M Nabikejje, Kishan Patel, Kathryn M Luly, Gaurav Gharti-Chhetry, Sonia Vallet, Homare Eda, Teru Hideshima, Simon R Green, Kenneth C. Anderson, David T. Scadden, Noopur Raje

Institutions: Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute, Cyclacel Pharmaceuticals (United Kingdom), Harvard Stem Cell Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589346682

FWCI:

Cites:

Cited by: 2

Related to: 10